TISSUE REGENIX GROUP

TRX
Delayed Quote. Delayed  - 07/15 11:35:29 am
0.33GBX --.--%
Prev.0.3300
Open0.3350
High0.3380
Low0.3300
Volume8 462 162
Latest news
02/04
05/2015
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBearishBearish
Resistance0,430,681,08
Spread/Res.-22%-51%-69%
Spread/Supp.2,8%2,8%2,8%
Support0,320,320,32
Financials
Sales 2019 13,0 M 16,4 M 16,4 M
Net income 2019 -6,97 M -8,78 M -8,78 M
Net cash 2019 0,09 M 0,12 M 0,12 M
P/E ratio 2019 -1,68x
Yield 2019 -
Capitalization 23,2 M 29,2 M 29,2 M
EV / Sales 2018 5,79x
EV / Sales 2019 0,88x
Nbr of Employees 99
Free-Float 78,1%
Company
Tissue Regenix Group plc is a medical technology company. The Company is engaged in the development of regenerative products to make replacement native tissue using biological (human and animal) tissues. It operates through Cardiac, Wound Care and Orthopaedics divisions. Its decellularisation...
Sector :
Biotechnology & Medical Research - NEC
Calendar :
2020-10-19 Earnings Release

Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 1
Average target price
Last Close Price 0,00 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -